Drugs (1 - 3 of 3 items) in Past Year
Drug Enforcement Administration: Additional Actions Needed to Address Prior GAO Recommendations
GAO-16-737T: Published: Jun 22, 2016. Publicly Released: Jun 22, 2016.
In three reports issued during 2015, GAO made eleven recommendations to the Drug Enforcement Administration (DEA) related to administering the quota process for controlled substances, providing information and guidance to registrants, and complying with guidelines for overseeing confidential informants. As of June 2016, DEA had taken some actions to address these recommendations but had fully impl...
Controlled Substances: DEA Should Take Additional Actions to Reduce Risks in Monitoring the Continued Eligibility of Its Registrants
GAO-16-310: Published: May 26, 2016. Publicly Released: Jun 21, 2016.
The Drug Enforcement Administration (DEA) has established controls for determining registrant eligibility to handle and prescribe controlled substances. However, GAO found limitations in DEA's controls to help ensure that individual registrants are and remain eligible and do not present issues that may increase the risk of illicit diversion. GAO's examination of DEA's controlled substances databas...
State Marijuana Legalization: DOJ Should Document Its Approach to Monitoring the Effects of Legalization
GAO-16-419T: Published: Apr 5, 2016. Publicly Released: Apr 5, 2016.
Officials from the Department of Justice's (DOJ) Office of the Deputy Attorney General (ODAG) reported monitoring the effects of state marijuana legalization relative to DOJ policy, generally in two ways. First, officials reported that U.S. Attorneys prosecute cases that threaten federal marijuana enforcement priorities (see fig. below) and consult with state officials about areas of federal conce...